0.68
+0.0369(+5.77%)
Currency In USD
| Previous Close | 0.64 |
| Open | 0.65 |
| Day High | 0.68 |
| Day Low | 0.64 |
| 52-Week High | 3.18 |
| 52-Week Low | 0.41 |
| Volume | 3.06M |
| Average Volume | 5.88M |
| Market Cap | 204.02M |
| PE | -2.6 |
| EPS | -0.26 |
| Moving Average 50 Days | 0.58 |
| Moving Average 200 Days | 0.72 |
| Change | 0.04 |
If you invested $1000 in Sangamo Therapeutics, Inc. (SGMO) 10 years ago, it would be worth $107.5 as of October 20, 2025 at a share price of $0.676. Whereas If you bought $1000 worth of Sangamo Therapeutics, Inc. (SGMO) shares 5 years ago, it would be worth $63.79 as of October 20, 2025 at a share price of $0.676.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
GlobeNewswire Inc.
Sep 04, 2025 12:05 PM GMT
Totality of data supports potential for isaralgagene civaparvovec as a one-time, durable treatment of the underlying pathology of Fabry disease to provide meaningful, multi-organ, clinical benefits above current standards of care STAAR study demonstr
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
GlobeNewswire Inc.
Jul 31, 2025 8:05 PM GMT
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets clos